170 related articles for article (PubMed ID: 6326022)
1. [Alpha-galactosidases and alpha-N-acetylgalactosaminidase. Biochemical bases of Fabry's disease].
Salvayre R; Negre A; Maret A; Douste-Blazy L
Pathol Biol (Paris); 1984 Apr; 32(4):269-84. PubMed ID: 6326022
[TBL] [Abstract][Full Text] [Related]
2. Differential assay for lysosomal alpha-galactosidases in human tissues and its application to Fabry's disease.
Mayes JS; Scheerer JB; Sifers RN; Donaldson ML
Clin Chim Acta; 1981 May; 112(2):247-51. PubMed ID: 6263521
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical study of unusual cases of Fabry disease].
Beĭer EM; Karpova EA; Udalova OV; Tsvetkova IV
Vopr Med Khim; 1998; 44(5):494-500. PubMed ID: 9916266
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of cDNA encoding alpha-N-acetylgalactosaminidase from Acremonium sp. and its expression in yeast.
Ashida H; Tamaki H; Fujimoto T; Yamamoto K; Kumagai H
Arch Biochem Biophys; 2000 Dec; 384(2):305-10. PubMed ID: 11368317
[TBL] [Abstract][Full Text] [Related]
5. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
Yuasa T; Fukuma M; Takashima S; Takaki R
Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
[TBL] [Abstract][Full Text] [Related]
6. Relationship of the multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase in the normal and in Fabry's disease.
Beyer E; Schono N; Kozlova I; Wiederschain G
Biochim Biophys Acta; 1990 May; 1038(3):386-9. PubMed ID: 2160280
[TBL] [Abstract][Full Text] [Related]
7. [Fabry-Anderson disease: current state of knowledge].
Vega-Vega O; Pérez-Gutiérrez A; Correa-Rotter R
Rev Invest Clin; 2011; 63(3):314-21. PubMed ID: 21888295
[TBL] [Abstract][Full Text] [Related]
8. [Substrate specificity of multiple forms of human alpha-D-galactosidase and alpha-D-fucosidase].
Baskaeva EM; Shono NI; Kozlova IK; Vidershaĭn GIa
Biokhimiia; 1989 Mar; 54(3):421-6. PubMed ID: 2546612
[TBL] [Abstract][Full Text] [Related]
9. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
Sheth KJ; Good TA; Murphy JV
Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
[TBL] [Abstract][Full Text] [Related]
10. [Molecular forms of human leukocytic alpha-galactosidase and N-acetyl-alpha-galactosaminidase].
Salvayre R; Maret A; Nègre A; Douste-Blazy L
C R Seances Acad Sci D; 1979 Mar; 288(12):995-8. PubMed ID: 223774
[TBL] [Abstract][Full Text] [Related]
11. Angiokeratoma corporis diffusum with glycopeptiduria due to deficient lysosomal alpha-N-acetylgalactosaminidase activity. Clinical, morphologic, and biochemical studies.
Kanzaki T; Yokota M; Irie F; Hirabayashi Y; Wang AM; Desnick RJ
Arch Dermatol; 1993 Apr; 129(4):460-5. PubMed ID: 8466216
[TBL] [Abstract][Full Text] [Related]
12. Pseudo-clinical Fabry's disease without alpha galactosidase deficiency.
Peltier A; Herbeuval E; Brondeau MT; Belleville F; Nabet P
Biomedicine; 1977 May; 26(3):194-201. PubMed ID: 407951
[TBL] [Abstract][Full Text] [Related]
13. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.
Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ
Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108
[TBL] [Abstract][Full Text] [Related]
14. Murine alpha-N-acetylgalactosaminidase: isolation and expression of a full-length cDNA and genomic organization: further evidence of an alpha-galactosidase gene family.
Wang AM; Ioannou YA; Zeidner KM; Desnick RJ
Mol Genet Metab; 1998 Oct; 65(2):165-73. PubMed ID: 9787108
[TBL] [Abstract][Full Text] [Related]
15. Glycosidases of Ehrlich ascites tumor cells and ascitic fluid--purification and substrate specificity of alpha-N-acetylgalactosaminidase and alpha-galactosidase: comparison with coffee bean alpha-galactosidase.
Yagi F; Eckhardt AE; Goldstein IJ
Arch Biochem Biophys; 1990 Jul; 280(1):61-7. PubMed ID: 2162155
[TBL] [Abstract][Full Text] [Related]
16. Effect of acid-base changes on urinary hydrolases in Fabry's disease after renal transplantation.
Berty RM; Adler S; Basu A; Glew RH
J Lab Clin Med; 1990 Jun; 115(6):696-703. PubMed ID: 2164077
[TBL] [Abstract][Full Text] [Related]
17. [Alpha-galactosidase A deficiency--Fabry's disease].
Tsuji S
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):745-8. PubMed ID: 2855953
[No Abstract] [Full Text] [Related]
18. Separation and properties of molecular forms of alpha-galactosidase and alpha-N-acetylgalactosaminidase from blood lymphocytes and lymphoid cell lines transformed by Epstein-Barr virus.
Salvayre R; Negre A; Maret A; Lenoir G; Douste-Blazy L
Biochim Biophys Acta; 1981 Jun; 659(2):445-56. PubMed ID: 6266491
[No Abstract] [Full Text] [Related]
19. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
Germain DP
J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
[TBL] [Abstract][Full Text] [Related]
20. [Angiokeratoma corporis diffusum (Fabry's disease). Biochemical diagnosis in plasma].
Atzpodien W; Kremer GJ; Schnellbacher E; Denk R; Haferkamp G; Bierbach H
Dtsch Med Wochenschr; 1975 Feb; 100(9):423-6. PubMed ID: 803896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
